샘플 요청 목록

 카트 문의
시장보고서
상품코드
1536112

세계 저분자 원료의약품 시장

Small Molecule API
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 379 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

저분자 원료의약품 세계 시장은 2030년까지 2,300억 달러에 달할 전망

2023년에 1,547억 달러로 추정되는 저분자 원료의약품 세계 시장은 2030년에는 2,300억 달러에 이르고, 분석 기간 2023-2030년의 CAGR은 5.8%로 성장할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 합성 분자는 CAGR 6.0%로 성장을 지속하고, 분석 기간 종료 시 1,835억 달러에 도달할 것으로 예상됩니다. 바이오분자 분야의 성장률은 분석 기간 동안 CAGR 5.3%로 추정됩니다.

미국 시장은 추정 421억 달러, 중국은 CAGR 9.4%로 성장 예측

미국의 저분자 원료 시장은 2023년 421억 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 489억 달러 규모에 이를 것으로 예측되며 분석 기간 2023-2030년의 CAGR은 9.4%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 2.4%와 5.9%로 예측되고 있습니다. 유럽에서는 독일이 CAGR 3.6%로 성장할 것으로 예측됩니다.

세계의 저분자 원료 시장 - 주요 동향과 촉진요인 요약

저분자 원료의약품(API)은 방대한 유형의 치료제의 개발 및 제조에 필수적인 요소입니다. 일반적으로 저분자인 것을 특징으로 하는 이들 분자는 세포막을 용이하게 투과하여 세포내의 작용 부위에 도달할 수 있기 때문에 다양한 질환의 치료에 높은 효과를 발휘합니다. 저분자 원료의약품은 일반적으로 고혈압, 당뇨병, 심혈관 질환 등의 만성 질환의 치료제나 항생제, 항바이러스제, 종양 치료제에 포함되어 있습니다. 이러한 원료의 제조에는 복잡한 화학 합성 공정이 필요하며, 그 효능과 안전성을 확보하기 위해 엄격한 품질 관리와 규제 준수가 요구됩니다. 제약회사는 암메트 메디컬 니즈에 대응하기 위해 보다 효과적이고 적정한 치료법의 창출을 목표로 저분자 원료의약품의 연구개발에 다액의 투자를 실시했습니다.

기술의 진보는 저분자 원료의약품의 개발·제조 공정를 현저하게 향상시키고 있습니다. 높은 처리량 스크리닝, 컴퓨팅 화학 및 분석 기술의 혁신으로 신규 원료의 발견과 최적화가 가속화되고 있습니다. 또한 생산 합리화, 비용 절감, 제품 일관성 향상을 위해 연속 제조 기술이 채택되었습니다. 게다가 그린케미스트리의 진보는 보다 환경적으로 지속가능한 합성법을 가능하게 하고, 원료제조에 의한 환경에 대한 영향을 경감하고 있습니다. 신약 개발의 인공지능(AI)과 머신러닝(ML)의 통합은 이 분야에 추가적인 변화를 가져 와서 분자의 거동을보다 정확하게 예측할 수있게되어 유망한 의약품 후보의 확인을 용이하게합니다. 했습니다. 이러한 기술적 진보는 원료의약품 개발의 효율성을 향상시킬 뿐만 아니라 복잡한 질환에 대한 새로운 치료법을 창출할 가능성을 넓혀가고 있습니다.

저분자 원료의약품 시장의 성장은 여러 요인에 의해 견인되고 있습니다. 만성 질환의 유병률 증가와 효과적이고 저렴한 의약품에 대한 지속적인 수요가 주요 촉진요인입니다. 세계 인구의 고령화와 개발도상국의 의료비 증가도 시장 확대에 기여하고 있습니다. 의약품 및 제조 기술의 진보는 생산 효율성을 높이고 비용을 절감하여 시장 성장을 가속하고 있습니다. 게다가, 개인화된 의료 동향은 표적화된 저분자 치료제의 개발을 필요로 하고, 혁신적인 원료의약품 수요를 끌어올리고 있습니다. 제네릭 의약품에 대한 규제 지원과 일부 블록버스터 의약품의 특허 해지는 비용 효율적인 제네릭 의약품의 생산을 촉진함으로써 시장 성장을 더욱 강화하고 있습니다. 지속가능한 제조방법에 대한 관심 증가는 기업이 시장에서 차별화를 도모할 수 있는 새로운 기회를 창출하고 있습니다. 이러한 동향이 진화를 계속하고 있는 가운데, 저분자 원료의약품 시장은 기술의 진보나 세계의 건강 과제에 대한 대응 중시의 고조에 견인되어 지속적인 성장을 이루려고 하고 있습니다.

조사 대상 기업 예(전 46건)

  • AbbVie Contract Manufacturing
  • AGC Pharma Chemicals Europe, SLU
  • Albemarle Corporation
  • Aurobindo Pharma Ltd.
  • Cambrex Corporation
  • Cipla Ltd.
  • Curia Inc.
  • Dr. Reddy's Active Pharmaceutical Ingredients
  • GL Chemtec International Ltd.
  • nkf-pharma
  • Patheon
  • Siegfried AG
  • Sterling Pharma Solutions
  • Sun Pharmaceutical Industries Ltd.
  • Teva Active Pharmaceutical Ingredients(A Division of Teva Pharmaceutical Industries Ltd.);

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

JHS 24.08.29

Global Small Molecule API Market to Reach US$230.0 Billion by 2030

The global market for Small Molecule API estimated at US$154.7 Billion in the year 2023, is expected to reach US$230.0 Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2023-2030. Synthetic Molecule, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$183.5 Billion by the end of the analysis period. Growth in the Biotech Molecule segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$42.1 Billion While China is Forecast to Grow at 9.4% CAGR

The Small Molecule API market in the U.S. is estimated at US$42.1 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$48.9 Billion by the year 2030 trailing a CAGR of 9.4% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.4% and 5.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.

Global Small Molecule API Market - Key Trends and Drivers Summarized

Small molecule active pharmaceutical ingredients (APIs) are critical components in the development and manufacture of a vast array of therapeutic drugs. These molecules, typically characterized by their low molecular weight, are able to easily penetrate cell membranes and reach intracellular sites of action, making them highly effective in treating various diseases. Small molecule APIs are commonly found in medications for chronic conditions such as hypertension, diabetes, and cardiovascular diseases, as well as in antibiotics, antiviral drugs, and oncology treatments. The production of these APIs involves complex chemical synthesis processes, requiring stringent quality control and regulatory compliance to ensure their efficacy and safety. Pharmaceutical companies invest heavily in the research and development of small molecule APIs, aiming to create more effective and targeted therapies to address unmet medical needs.

Technological advancements have significantly enhanced the development and manufacturing processes of small molecule APIs. Innovations in high-throughput screening, computational chemistry, and analytical techniques have accelerated the discovery and optimization of new APIs. Continuous manufacturing technologies have also been adopted to streamline production, reduce costs, and improve product consistency. Moreover, advancements in green chemistry have allowed for more environmentally sustainable synthesis methods, reducing the environmental impact of API production. The integration of artificial intelligence (AI) and machine learning (ML) in drug discovery and development has further revolutionized the field, enabling more precise prediction of molecular behavior and facilitating the identification of promising drug candidates. These technological strides have not only increased the efficiency of API development but have also expanded the potential for creating novel treatments for complex diseases.

The growth in the small molecule API market is driven by several factors. Increasing prevalence of chronic diseases and the ongoing demand for effective and affordable medications are primary drivers. The aging global population and rising healthcare expenditures in developing countries are also contributing to market expansion. Technological advancements in drug discovery and manufacturing are propelling market growth by enhancing production efficiency and reducing costs. Additionally, the trend towards personalized medicine, which requires the development of targeted small molecule therapies, is boosting demand for innovative APIs. Regulatory support for generic drugs and the expiration of patents for several blockbuster drugs are further fueling market growth by encouraging the production of cost-effective generic APIs. The increasing focus on sustainable manufacturing practices is generating new opportunities for companies to differentiate themselves in the market. As these trends continue to evolve, the small molecule API market is poised for sustained growth, driven by advancements in technology and a growing emphasis on addressing global health challenges.

Select Competitors (Total 46 Featured) -

  • AbbVie Contract Manufacturing
  • AGC Pharma Chemicals Europe, S.L.U.
  • Albemarle Corporation
  • Aurobindo Pharma Ltd.
  • Cambrex Corporation
  • Cipla Ltd.
  • Curia Inc.
  • Dr. Reddy's Active Pharmaceutical Ingredients
  • GL Chemtec International Ltd.
  • nkf-pharma
  • Patheon
  • Siegfried AG
  • Sterling Pharma Solutions
  • Sun Pharmaceutical Industries Ltd.
  • Teva Active Pharmaceutical Ingredients (A Division of Teva Pharmaceutical Industries Ltd.);

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Small Molecule API - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Chronic Diseases Propels Demand for Small Molecule APIs
    • Advances in High-Throughput Screening Technologies Strengthen Drug Discovery Efforts
    • Integration of Artificial Intelligence in Drug Development Throws Spotlight on Innovation
    • Adoption of Continuous Manufacturing Processes Drives Efficiency and Cost Reduction
    • Expansion of Personalized Medicine Expands Addressable Market Opportunity
    • Rise in Healthcare Expenditures in Developing Countries Spurs Market Growth
    • Expiration of Patents for Blockbuster Drugs Accelerates Demand for Generic APIs
    • Increasing Focus on Targeted Small Molecule Therapies Drives Adoption
    • Growing Investment in R&D by Pharmaceutical Companies Propels Market Innovation
    • Technological Innovations in Computational Chemistry Drive New Drug Discoveries
    • Rising Demand for Effective and Affordable Medications Generates Market Opportunities
    • Growth of Outsourcing in API Manufacturing Propels Market Expansion
    • Increasing Use of Machine Learning in Predictive Analysis for Drug Development Drives Efficiency
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Small Molecule API Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Small Molecule API by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Small Molecule API by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Small Molecule API by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Synthetic Molecule by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Synthetic Molecule by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Synthetic Molecule by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Biotech Molecule by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Biotech Molecule by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Biotech Molecule by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for In-House Manufacturing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for In-House Manufacturing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for In-House Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Outsourced Manufacturing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Outsourced Manufacturing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Outsourced Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Cardiovascular Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Cardiovascular Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Cardiovascular Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Oncology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Diabetes Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Diabetes Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Diabetes Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Immunological Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Immunological Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Immunological Disorders Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Small Molecule API Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Small Molecule API by Molecule - Percentage Breakdown of Value Sales for Synthetic Molecule and Biotech Molecule for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Small Molecule API by Manufacturing Type - Percentage Breakdown of Value Sales for In-House Manufacturing and Outsourced Manufacturing for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Small Molecule API by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Small Molecule API by Molecule - Percentage Breakdown of Value Sales for Synthetic Molecule and Biotech Molecule for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Small Molecule API by Manufacturing Type - Percentage Breakdown of Value Sales for In-House Manufacturing and Outsourced Manufacturing for the Years 2014, 2024 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Small Molecule API by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications for the Years 2014, 2024 & 2030
  • JAPAN
    • Small Molecule API Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Small Molecule API by Molecule - Percentage Breakdown of Value Sales for Synthetic Molecule and Biotech Molecule for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Small Molecule API by Manufacturing Type - Percentage Breakdown of Value Sales for In-House Manufacturing and Outsourced Manufacturing for the Years 2014, 2024 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Small Molecule API by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications for the Years 2014, 2024 & 2030
  • CHINA
    • Small Molecule API Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Small Molecule API by Molecule - Percentage Breakdown of Value Sales for Synthetic Molecule and Biotech Molecule for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Small Molecule API by Manufacturing Type - Percentage Breakdown of Value Sales for In-House Manufacturing and Outsourced Manufacturing for the Years 2014, 2024 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: China 16-Year Perspective for Small Molecule API by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications for the Years 2014, 2024 & 2030
  • EUROPE
    • Small Molecule API Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Small Molecule API by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Small Molecule API by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Small Molecule API by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Small Molecule API by Molecule - Percentage Breakdown of Value Sales for Synthetic Molecule and Biotech Molecule for the Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Small Molecule API by Manufacturing Type - Percentage Breakdown of Value Sales for In-House Manufacturing and Outsourced Manufacturing for the Years 2014, 2024 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Small Molecule API by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications for the Years 2014, 2024 & 2030
  • FRANCE
    • Small Molecule API Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: France 16-Year Perspective for Small Molecule API by Molecule - Percentage Breakdown of Value Sales for Synthetic Molecule and Biotech Molecule for the Years 2014, 2024 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Small Molecule API by Manufacturing Type - Percentage Breakdown of Value Sales for In-House Manufacturing and Outsourced Manufacturing for the Years 2014, 2024 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: France 16-Year Perspective for Small Molecule API by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications for the Years 2014, 2024 & 2030
  • GERMANY
    • Small Molecule API Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Small Molecule API by Molecule - Percentage Breakdown of Value Sales for Synthetic Molecule and Biotech Molecule for the Years 2014, 2024 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Small Molecule API by Manufacturing Type - Percentage Breakdown of Value Sales for In-House Manufacturing and Outsourced Manufacturing for the Years 2014, 2024 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Small Molecule API by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Small Molecule API by Molecule - Percentage Breakdown of Value Sales for Synthetic Molecule and Biotech Molecule for the Years 2014, 2024 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Small Molecule API by Manufacturing Type - Percentage Breakdown of Value Sales for In-House Manufacturing and Outsourced Manufacturing for the Years 2014, 2024 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Small Molecule API by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Small Molecule API Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 107: UK Recent Past, Current & Future Analysis for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Small Molecule API by Molecule - Percentage Breakdown of Value Sales for Synthetic Molecule and Biotech Molecule for the Years 2014, 2024 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Small Molecule API by Manufacturing Type - Percentage Breakdown of Value Sales for In-House Manufacturing and Outsourced Manufacturing for the Years 2014, 2024 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Small Molecule API by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Spain 16-Year Perspective for Small Molecule API by Molecule - Percentage Breakdown of Value Sales for Synthetic Molecule and Biotech Molecule for the Years 2014, 2024 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Spain 16-Year Perspective for Small Molecule API by Manufacturing Type - Percentage Breakdown of Value Sales for In-House Manufacturing and Outsourced Manufacturing for the Years 2014, 2024 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Spain 16-Year Perspective for Small Molecule API by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Russia 16-Year Perspective for Small Molecule API by Molecule - Percentage Breakdown of Value Sales for Synthetic Molecule and Biotech Molecule for the Years 2014, 2024 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Russia 16-Year Perspective for Small Molecule API by Manufacturing Type - Percentage Breakdown of Value Sales for In-House Manufacturing and Outsourced Manufacturing for the Years 2014, 2024 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Russia 16-Year Perspective for Small Molecule API by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Small Molecule API by Molecule - Percentage Breakdown of Value Sales for Synthetic Molecule and Biotech Molecule for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Small Molecule API by Manufacturing Type - Percentage Breakdown of Value Sales for In-House Manufacturing and Outsourced Manufacturing for the Years 2014, 2024 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of Europe 16-Year Perspective for Small Molecule API by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Small Molecule API Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Small Molecule API by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Small Molecule API by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Small Molecule API by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Small Molecule API by Molecule - Percentage Breakdown of Value Sales for Synthetic Molecule and Biotech Molecule for the Years 2014, 2024 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Small Molecule API by Manufacturing Type - Percentage Breakdown of Value Sales for In-House Manufacturing and Outsourced Manufacturing for the Years 2014, 2024 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Asia-Pacific 16-Year Perspective for Small Molecule API by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Small Molecule API Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Australia 16-Year Perspective for Small Molecule API by Molecule - Percentage Breakdown of Value Sales for Synthetic Molecule and Biotech Molecule for the Years 2014, 2024 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Australia 16-Year Perspective for Small Molecule API by Manufacturing Type - Percentage Breakdown of Value Sales for In-House Manufacturing and Outsourced Manufacturing for the Years 2014, 2024 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Australia 16-Year Perspective for Small Molecule API by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications for the Years 2014, 2024 & 2030
  • INDIA
    • Small Molecule API Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 164: India Recent Past, Current & Future Analysis for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: India 16-Year Perspective for Small Molecule API by Molecule - Percentage Breakdown of Value Sales for Synthetic Molecule and Biotech Molecule for the Years 2014, 2024 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: India 16-Year Perspective for Small Molecule API by Manufacturing Type - Percentage Breakdown of Value Sales for In-House Manufacturing and Outsourced Manufacturing for the Years 2014, 2024 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: India 16-Year Perspective for Small Molecule API by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: South Korea 16-Year Perspective for Small Molecule API by Molecule - Percentage Breakdown of Value Sales for Synthetic Molecule and Biotech Molecule for the Years 2014, 2024 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: South Korea 16-Year Perspective for Small Molecule API by Manufacturing Type - Percentage Breakdown of Value Sales for In-House Manufacturing and Outsourced Manufacturing for the Years 2014, 2024 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: South Korea 16-Year Perspective for Small Molecule API by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Small Molecule API by Molecule - Percentage Breakdown of Value Sales for Synthetic Molecule and Biotech Molecule for the Years 2014, 2024 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Small Molecule API by Manufacturing Type - Percentage Breakdown of Value Sales for In-House Manufacturing and Outsourced Manufacturing for the Years 2014, 2024 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Small Molecule API by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Small Molecule API Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Small Molecule API by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Small Molecule API by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Small Molecule API by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Small Molecule API by Molecule - Percentage Breakdown of Value Sales for Synthetic Molecule and Biotech Molecule for the Years 2014, 2024 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Small Molecule API by Manufacturing Type - Percentage Breakdown of Value Sales for In-House Manufacturing and Outsourced Manufacturing for the Years 2014, 2024 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Latin America 16-Year Perspective for Small Molecule API by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Argentina 16-Year Perspective for Small Molecule API by Molecule - Percentage Breakdown of Value Sales for Synthetic Molecule and Biotech Molecule for the Years 2014, 2024 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Argentina 16-Year Perspective for Small Molecule API by Manufacturing Type - Percentage Breakdown of Value Sales for In-House Manufacturing and Outsourced Manufacturing for the Years 2014, 2024 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Argentina 16-Year Perspective for Small Molecule API by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Brazil 16-Year Perspective for Small Molecule API by Molecule - Percentage Breakdown of Value Sales for Synthetic Molecule and Biotech Molecule for the Years 2014, 2024 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Brazil 16-Year Perspective for Small Molecule API by Manufacturing Type - Percentage Breakdown of Value Sales for In-House Manufacturing and Outsourced Manufacturing for the Years 2014, 2024 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 220: Brazil 16-Year Perspective for Small Molecule API by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 223: Mexico 16-Year Perspective for Small Molecule API by Molecule - Percentage Breakdown of Value Sales for Synthetic Molecule and Biotech Molecule for the Years 2014, 2024 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 226: Mexico 16-Year Perspective for Small Molecule API by Manufacturing Type - Percentage Breakdown of Value Sales for In-House Manufacturing and Outsourced Manufacturing for the Years 2014, 2024 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 229: Mexico 16-Year Perspective for Small Molecule API by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 232: Rest of Latin America 16-Year Perspective for Small Molecule API by Molecule - Percentage Breakdown of Value Sales for Synthetic Molecule and Biotech Molecule for the Years 2014, 2024 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 235: Rest of Latin America 16-Year Perspective for Small Molecule API by Manufacturing Type - Percentage Breakdown of Value Sales for In-House Manufacturing and Outsourced Manufacturing for the Years 2014, 2024 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 238: Rest of Latin America 16-Year Perspective for Small Molecule API by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Small Molecule API Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Small Molecule API by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Small Molecule API by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 241: Middle East 16-Year Perspective for Small Molecule API by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Small Molecule API by Molecule - Percentage Breakdown of Value Sales for Synthetic Molecule and Biotech Molecule for the Years 2014, 2024 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Small Molecule API by Manufacturing Type - Percentage Breakdown of Value Sales for In-House Manufacturing and Outsourced Manufacturing for the Years 2014, 2024 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 250: Middle East 16-Year Perspective for Small Molecule API by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 253: Iran 16-Year Perspective for Small Molecule API by Molecule - Percentage Breakdown of Value Sales for Synthetic Molecule and Biotech Molecule for the Years 2014, 2024 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 256: Iran 16-Year Perspective for Small Molecule API by Manufacturing Type - Percentage Breakdown of Value Sales for In-House Manufacturing and Outsourced Manufacturing for the Years 2014, 2024 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 259: Iran 16-Year Perspective for Small Molecule API by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 262: Israel 16-Year Perspective for Small Molecule API by Molecule - Percentage Breakdown of Value Sales for Synthetic Molecule and Biotech Molecule for the Years 2014, 2024 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 265: Israel 16-Year Perspective for Small Molecule API by Manufacturing Type - Percentage Breakdown of Value Sales for In-House Manufacturing and Outsourced Manufacturing for the Years 2014, 2024 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 268: Israel 16-Year Perspective for Small Molecule API by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 271: Saudi Arabia 16-Year Perspective for Small Molecule API by Molecule - Percentage Breakdown of Value Sales for Synthetic Molecule and Biotech Molecule for the Years 2014, 2024 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 274: Saudi Arabia 16-Year Perspective for Small Molecule API by Manufacturing Type - Percentage Breakdown of Value Sales for In-House Manufacturing and Outsourced Manufacturing for the Years 2014, 2024 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 277: Saudi Arabia 16-Year Perspective for Small Molecule API by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 280: UAE 16-Year Perspective for Small Molecule API by Molecule - Percentage Breakdown of Value Sales for Synthetic Molecule and Biotech Molecule for the Years 2014, 2024 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 283: UAE 16-Year Perspective for Small Molecule API by Manufacturing Type - Percentage Breakdown of Value Sales for In-House Manufacturing and Outsourced Manufacturing for the Years 2014, 2024 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 286: UAE 16-Year Perspective for Small Molecule API by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 289: Rest of Middle East 16-Year Perspective for Small Molecule API by Molecule - Percentage Breakdown of Value Sales for Synthetic Molecule and Biotech Molecule for the Years 2014, 2024 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 292: Rest of Middle East 16-Year Perspective for Small Molecule API by Manufacturing Type - Percentage Breakdown of Value Sales for In-House Manufacturing and Outsourced Manufacturing for the Years 2014, 2024 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 295: Rest of Middle East 16-Year Perspective for Small Molecule API by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications for the Years 2014, 2024 & 2030
  • AFRICA
    • Small Molecule API Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Small Molecule API by Molecule - Synthetic Molecule and Biotech Molecule Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 298: Africa 16-Year Perspective for Small Molecule API by Molecule - Percentage Breakdown of Value Sales for Synthetic Molecule and Biotech Molecule for the Years 2014, 2024 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Small Molecule API by Manufacturing Type - In-House Manufacturing and Outsourced Manufacturing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 301: Africa 16-Year Perspective for Small Molecule API by Manufacturing Type - Percentage Breakdown of Value Sales for In-House Manufacturing and Outsourced Manufacturing for the Years 2014, 2024 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Small Molecule API by Application - Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 304: Africa 16-Year Perspective for Small Molecule API by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases Application, Oncology Application, Diabetes Application, Immunological Disorders Application and Other Applications for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제